乌司他丁对重症脓毒症患者肠屏障功能及菌群移位的影响

黄巍

（桂林医学院附属医院重症医学科一病区，广西 桂林，541001）

浏览次数：148次 下载次数：461次

摘要：

目的 探讨乌司他丁对重症脓毒症患者肠屏障功能及菌群移位的影响。方法 选择2013 年1 月至2015 年12 月我院收 治的重症脓毒症患者80 例，按照随机数字法分为观察组与对照组，各40 例。对照组行常规治疗，包括抗菌、维持内环境稳 定、营养支持等对症支持处理，观察组在对照组基础上使用乌司他丁注射液治疗。比较治疗前、后两组患者的血清内毒素水 平及24 h 尿99 mTc-DTPA 排泄率。结果 治疗后，两组的血清内毒素水平明显低于治疗前，且观察组明显低于对照组（P< 0.05）。治疗后，两组的24 h 尿99 mTc-DTPA 排泄率明显高于治疗前，且观察组明显高于对照组（P<0.05）。结论 重症脓毒症 患者使用乌司他丁能有效提高胃肠道屏障功能，降低胃肠道中内毒素水平，进而提高胃肠道功能。

关键词：乌司他丁；重症脓毒症；肠屏障功能；菌群移位

中图分类号：R459.7文献标志码：A文章编号：2096-1413(2018)01-0016-02

Effects of ulinastatin on intestinal barrier function and flora translocation in patients with severe sepsis
HUANG Wei
(Intensive Care Unit Department No.1 Ward, Affiliated Hospital of Guilin Medical University, Guilin 541001, China)

ABSTRACT: Objective To investigate the effect of ulinastatin on intestinal barrier function and flora translation in patients with severe sepsis. Methods Eighty cases of severe sepsis patients admitted in our hospital from January 2013 to December 2015 were divided into observation group and control group according to the random number method, with 40 cases in each group. The control group was treated with routine treatment, such as antibacterial, maintenance of internal stability, nutritional support and other symptomatic support treatment; and the observation group was given ulinastatin based on the control group. The levels of serum endotoxin and the urinary 99 mTc-DTPA excretion rates in 24 h were compared between the two groups. Results After treatment, the levels of serum endotoxin of the two groups were lower than those before treatment, and those of the observation group were lower than the control group (P<0.05). After treatment, the 24 h urinary 99 mTc-DTPA excretion levels of the two groups were higher than those before treatment, and those of the observation group were higher than the control group (P<0.05). Conclusion Ulinastatin can improve gastrointestinal barrier function, reduce endotoxin level in gastrointestinal tract and improve gastrointestinal function in patients with severe sepsis.
KEYWORDS: ulinastatin; severe sepsis; intestinal barrier function; flora translocation

参考文献：
[1] 俞兆希,石松菁,沈阳辉.乌司他丁对脓毒症大鼠血管内皮细胞功能保护作用研究[J].中华实用诊断与治疗杂志,2013,27(10):968-969.
[2] 赵梦雅,李昂,张淑文,等.参麦注射液及乌司他丁对重症脓毒症患者微循环的影响[J].首都医科大学学报,2012,33(3):297-300.
[3] 黄朝刚,李垒,刘保池.HIV 感染者围术期发生脓毒症的临床特点及乌司他丁治疗效果分析[J].中国全科医学,2015,18(11):1330-1332.
[4] 田先雨,黄卫东,韩再萍,等.乌司他丁辅助治疗脓毒症患儿外周血 一氧化氮和诱导型一氧化氮合酶浓度变化的研究[J].儿科药学杂志,2014,20(3):1-3.
[5] 吴铁军,张丽娜,亢翠翠.乌司他丁对重症脓毒症患者Treg/Th17 的影响[J].中国呼吸与危重监护杂志,2013,12(3):240-243.
[6] 杨春辉,王璐,李虎,等.乌司他丁对重度脓毒症诱导的ALI/ARDS模型大鼠肺组织中蛋白C 及活化蛋白C 含量的影响[J].中国临床 医学,2013,20(4):447-449.
[7] 廖培军,李忠勇,金仙珍.血必净联用乌司他丁治疗重症脓毒症有 效性的系统评价[J].中国实验方剂学杂志,2014,20(22):232-237.